Gastroesophageal reflux disease and the relationship with Helicobacter pylori

dc.authoridBinnur Pınarbaşı Şimşek / 0000-0003-3412-3976en_US
dc.authorscopusidBinnur Pınarbaşı Şimşek / 57199508680
dc.authorwosidBinnur Pınarbaşı Şimşek / FTI-5172-2022
dc.contributor.authorMungan, Zeynel
dc.contributor.authorPınarbaşı Şimşek, Binnur
dc.date.accessioned2020-08-30T20:08:00Z
dc.date.available2020-08-30T20:08:00Z
dc.date.issued2017
dc.departmentİstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractAfter Helicobacter pylori was identified, and its relationship with peptic ulcer disease was exactly shown, the relationship of this bacterium with gastroesophageal reflux disease (GERD) gained momentum and discussions continue to this day. We reviewed the literature for the relationship between H. pylori and GERD. According to the existing data, there is no relationship between GERD and H. pylori presence. Successful eradication therapy does not have an impact on the emergence or exacerbation of GERD. However Barrett's esophagus and esophageal adenocarcinoma are less frequent, especially in the presence of CagA positive H. pylori infections. Longterm use of proton pump inhibitor (PPI) may have an impact on the development of atrophy and/or intestinal metaplasia in H. pylori positive patients; therefore, H. pylori eradication is recommended in patients that should use long-term PPI. As a conclusion, H. pylori screening and the eradication decision should be independent of GERD, except for patients that will use long-term PPI.en_US
dc.identifier.citationMungan, Z., & Şimşek, B. P. (2017). Gastroesophageal reflux disease and the relationship with helicobacter pylori. Turkish Journal of Gastroenterology, 28, S61–S67. https://doi.org/10.5152/tjg.2017.16en_US
dc.identifier.doi10.5152/tjg.2017.16en_US
dc.identifier.endpageS67en_US
dc.identifier.issn1300-4948en_US
dc.identifier.issn2148-5607en_US
dc.identifier.pmid29199171en_US
dc.identifier.scopus2-s2.0-85050434600en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpageS61en_US
dc.identifier.trdizinid267561en_US
dc.identifier.urihttps://doi.org/10.5152/tjg.2017.16
dc.identifier.urihttps://hdl.handle.net/20.500.12713/867
dc.identifier.volume28en_US
dc.identifier.wosWOS:000417204500015en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorPınarbaşı Şimşek, Binnuren_US
dc.language.isoenen_US
dc.publisherAvesen_US
dc.relation.ispartofTurkish Journal of Gastroenterologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectHelicobacter Pylorien_US
dc.subjectGastroesophageal Reflux Diseaseen_US
dc.subjectProton Pump Inhibitorsen_US
dc.subjectGastric Atrophyen_US
dc.subjectEsophagus Canceren_US
dc.subjectBarrett Esophagusen_US
dc.titleGastroesophageal reflux disease and the relationship with Helicobacter pylorien_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
H103.pdf
Boyut:
155.26 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text